| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $15K | — | -81.5% |
| Cost of Revenue | $0 | — | -100.0% |
| R&D Expense | $329K | — | -77.8% |
| SG&A Expense | $1.7M | — | -34.2% |
| Operating Income | -$2.1M | — | +49.4% |
| Interest Expense | $791K | — | +30.1% |
| Pre-tax Income | -$8.1M | — | -977.4% |
| Income Tax | $0 | — | — |
| Net Income | -$8.1M | — | -977.4% |
| EPS (Basic) | -$0.69 | — | -666.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $5.9M | +14.5% | -39.6% |
| Inventory | $54K | +45.9% | +42.1% |
| Current Assets | $13.0M | +45.1% | -11.2% |
| Total Assets | $21.7M | +19.5% | -14.4% |
| Current Liabilities | $6.7M | -37.5% | -37.5% |
| Long-term Debt | $17.7M | -0.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.5M | — | +9.6% |
| Investing Cash Flow | $0 | — | — |
| Financing Cash Flow | $5.2M | — | +95.8% |
| +6.4% |
| Total Liabilities | $40.5M | +13.3% | +33.6% |
| Stockholders' Equity | -$18.8M | -6.9% | -278.2% |